Breaking Minnesota Twins Acquire Left-Handed Reliever A.J. Minter in Trade with New York Mets Former Sri Lankan Police Chief Sentenced to Death Over 2019 Easter Bombings Photographer Captures Tour de France Speed Through Motion Blur Technique Oprah Winfrey’s South African Leadership Academy for Girls to Close, Transition to Provincial Education Department Father Seeks Travel Exemption for Son’s Funeral Amidst Negligence Charges

Friday July 31, 2026

Reporter

Dyne Therapeutics, Inc.

5Articles Published

5Communities Covered

Published Articles

Press Release

Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Jul 29

Press Release

Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

Jul 28

Press Release

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 24

Press Release

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Jul 23

Press Release

Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock

Jul 21